Resultados de la búsqueda

Santos-Beneit G, Fernández-Jiménez R, Fuster V. Education and Information to Improve Cardiovascular Health-Reply. JAMA Cardiol (2024) 9:306-307

Goldman SA, Requena-Ibanez JA, Devesa A, Santos-Gallego CG, Badimon JJ, Fuster V. Uncovering the Role of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction. JACC Adv (2024) 2:100657.

Fiolet ATL, Poorthuis MHF, Opstal TSJ, Amarenco P, Boczar KE, Buysschaert I, Budgeon C, Chan NC, Cornel JH, Jolly SS, Layland J, Lemmens R, Mewton N, Nidorf SM, Pascual-Figal DA, Price C, Shah B, Tardif JC, Thompson PL, Tijssen JGP, Tsivgoulis G, Walsh C, Wang Y, Weimar C, Eikelboom JW, Mosterd A, Kelly PJ; Colchicine Cardiovascular Trialists Collaboration. Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials. EClinicalMedicine (2024) 76:102835

Pascual-Figal D, Bayes-Genis A. Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review. Front Cardiovasc Med (2024) 11:1439696

Bayes-Genis A, Pascual-Figal D. Making STRONGer the transition phase: personalized GDMT through NT-proBNP monitoring. Eur Heart J (2023) 44:2963-2965.
Link to the full text in Repisalud

Mensah GA, Fuster V, Roth GA. A Heart-Healthy and Stroke-Free World: Using Data to Inform Global Action. J Am Coll Cardiol (2023) 82:2343-2349
Link to the full text in Repisalud

Mensah GA, Fuster V, Murray CJL, Roth GA; Global Burden of Cardiovascular Diseases and Risks Collaborators. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol (2023) 82:2350-247
Link to the full text in Repisalud

Barreiro-Pérez M, Pueyo PP, Roubin SR, Corominas DM, Uribarri A, Bachiller RE, Rozado Castaño J, Álvarez LG, Fernández LS, Domínguez F, Figal DP. Consenso de expertos sobre el diagnóstico y el tratamiento de la miocarditis asociada con infección o vacunación contra el SARS-CoV-2 [Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management]. Rev Esp Cardiol (2023) 76:555-563
Link to the full text in Repisalud

Pascual-Figal D, Lax A, Asensio López MC. Circulating ST2, from biomarker to pathogenic mediator. Rev Esp Cardiol (2023) S1885-5857(23)00102-0
Link to the full text in Repisalud

Straburzynska-Migaj E, Senni M, Wachter R, Fonseca C, Witte KK, Mueller C, Lonn E, Butylin D, Noe A, Schwende H, Lawrence D, Suryawanshi B, Pascual-Figal D; of TRANSITION Investigators. Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION Study J Card Fail (2023) 30:425-43
Link to the full text in Repisalud